DRD4 Antikörper (AA 151-250) (Cy7)

Produktnummer ABIN733859

Produktdetails anti-DRD4 Antikörper (Cy7)

Target: DRD4 (Dopamine Receptor D4 (DRD4))

Bindungsspezifität: AA 151-250

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser DRD4 Antikörper ist konjugiert mit Cy7

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Kreuzreaktivität: Human, Maus

Homologie: Rat

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human DRD4

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu DRD4

Target: DRD4 (Dopamine Receptor D4 (DRD4))

Andere Bezeichnung: Drd4 (DRD4 Produkte)

Synonyme: Drd4b antikoerper, si:ch211-69h5.1 antikoerper, zgc:123021 antikoerper, D4DR antikoerper, AW125663 antikoerper, D4R antikoerper, Drd-4 antikoerper, D4RA antikoerper, DRD4 antikoerper, Drd4c antikoerper, dopamine receptor D4 related sequence antikoerper, dopamine receptor D4 antikoerper, dopamine receptor D4b antikoerper, drd4-rs antikoerper, DRD4 antikoerper, Drd4 antikoerper, SRU_2808 antikoerper, MSMEG_3522 antikoerper, drd4b antikoerper

Hintergrund:

Synonyms: DRD4 receptor, dopamine D4 receptor, D4 dopamine receptor, DRD4_HUMAN.

Background: This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats, the sequence shown contains four repeats.DRD4 expression has been reported in various regions of the brain as well as in adrenal gland, artery, eye, heart, kidney, placenta, spinal cord, testis, and vas deferens.

Gen-ID: 1815

UniProt: P21917

Pathways: cAMP Metabolic Process, Synaptic Membrane, Proton Transport, Photoperiodism, Negative Regulation of Transporter Activity